MDNCOTCSurgical & Medical Instruments & ApparatusFiscal year ends February 28
Medinotec Inc.
Financials through Q2 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$5.00+0.00 (0.00%)
Close on Oct 16, 2026
- Market cap
- $58.78M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
$0.00 (0.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Medinotec Inc. saw revenue fall 10.9% to $10.21M over the twelve months to Aug 31, 2026. Operating income fell 79.6% to $672.09K, moving the operating margin from 28.7% to 6.6%. Free cash flow was $905.44K, up 14.8% from a year earlier.
Revenue
$10.21M
-10.9% vs. a year earlier
Operating income
$672.09K
-79.6% vs. a year earlier
Free cash flow
$905.44K
+14.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Aug 31, 2026
Valuation
- Market cap
- $58.78M
- P/E ratio
- –
- Price to sales
- 5.76
- Price to book
- 9.91
- Dividend yield
- –
- Free cash flow yield
- 1.54%
Fundamentals
- Revenue
- $10.21M
- Net income
- $597.03K
- Free cash flow
- $905.44K
- Book value per share
- $0.50
- Diluted shares
- 12M
Five years at a glance
Fiscal years 2022 to 2026 and trailing twelve months, USD
Revenue
$10.21M-10.9% YoY
Gross profit
$5.07M-19.3% YoY
Operating income
$672.09K-79.6% YoY
Net income
$597.03K-73.4% YoY
Free cash flow
–
Reported periodTrailing twelve months